Zhenzhen Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhenzhen Zhao has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Shousheng Liu
Qingdao Municipal Hospital Central Laboratory, Qingdao 266000, China
2 shared publications - Yongning Xin
Department of Infectious Diseases, Qingdao Municipal Hospital, Qingdao 266011, China
2 shared publications - Bing Luo
Department of Pathogenic Biology, School of Basic Medicine Qingdao University Qingdao China
1 shared publication - Binwu Ying
Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital Sichuan University, Sichuan Clinical Research Center for Laboratory Medicine Sichuan P. R. China
1 shared publication Danrui Zhao
Department of Medical Microbiology, Qingdao University Medical College, Qingdao, China
1 shared publication- Hao Bai
Precision Medicine Translational Research Center (PMTRC), West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China
1 shared publication
Latest Publications
- 20 September 2023
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 6 (19) , 17615-17625
MOF-808/Polyamide Thin-Film Nanocomposite Membranes for Efficient Nanofiltration
- 20 September 2023
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 6 (19) , 17615-17625
MOF-808/Polyamide Thin-Film Nanocomposite Membranes for Efficient Nanofiltration
- Open Access
- 9 December 2020
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000) , 1-12
Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease
Accumulated studies have reported the key role of circulating fetuin-A in the development and progression of nonalcoholic fatty liver disease (NAFLD) but the results have not been consistent. In this study, we performed a systematic review and meta-analysis to explore the relationship between circulating fetuin-A level and the development and classification of NAFLD.
- 9 December 2020
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000) , 1-12
Open AccessSystematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease
Accumulated studies have reported the key role of circulating fetuin-A in the development and progression of nonalcoholic fatty liver disease (NAFLD) but the results have not been consistent. In this study, we performed a systematic review and meta-analysis to explore the relationship between circulating fetuin-A level and the development and classification of NAFLD.
- Open Access
- 3 November 2019
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2019, 1-7
Association of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease with FADS2 rs3834458 Gene Polymorphism in the Chinese Han Population
Background. Nonalcoholic fatty liver disease (NAFLD) patients are often prone to coronary artery disease (CAD), and CAD is found to be the main cause of death in NAFLD patients. The purpose of this study was to investigate the association between fatty acid desaturase 2 (FADS2) rs3834458 polymorphism and serum FADS2 level with NAFLD and CAD in Chinese Han population. Materials and Methods. The serum level of FADS2 was detected by enzyme-linked immunosorbent assay (ELISA) in healthy people, NAFLD patients, and NAFLD patients combined with CAD (NAFLD+CAD). Polymerase chain reaction (PCR) was used to detect the genotypes of FADS2 rs3834458 in the three groups. Results. Body mass index (BMI), glucose (GLU), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) of the NAFLD group and the NAFLD+CAD group were higher than those of the healthy control group (); the HDL-C of the NAFLD+CAD group was significantly lower than that of the healthy people and the NAFLD group (). The serum FADS2 concentration in the NAFLD+CAD group was significantly higher than that in the NAFLD group () and the healthy people (). There was no significant difference in genotype distribution (, ) and allele frequency (, ) between the three groups. Logistic regression analysis showed that the T allele was not an independent risk factor for CAD with NAFLD (, 95% CI: 0.422-6.180). Conclusions. Serum FADS2 concentration was positively correlated with the susceptibility of NAFLD with CAD, while the polymorphism of rs3834458 was not associated with NAFLD with CAD.- 3 November 2019
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2019, 1-7
Open AccessAssociation of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease with FADS2 rs3834458 Gene Polymorphism in the Chinese Han Population
Background. Nonalcoholic fatty liver disease (NAFLD) patients are often prone to coronary artery disease (CAD), and CAD is found to be the main cause of death in NAFLD patients. The purpose of this study was to investigate the association between fatty acid desaturase 2 (FADS2) rs3834458 polymorphism and serum FADS2 level with NAFLD and CAD in Chinese Han population. Materials and Methods. The serum level of FADS2 was detected by enzyme-linked immunosorbent assay (ELISA) in healthy people, NAFLD patients, and NAFLD patients combined with CAD (NAFLD+CAD). Polymerase chain reaction (PCR) was used to detect the genotypes of FADS2 rs3834458 in the three groups. Results. Body mass index (BMI), glucose (GLU), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) of the NAFLD group and the NAFLD+CAD group were higher than those of the healthy control group (); the HDL-C of the NAFLD+CAD group was significantly lower than that of the healthy people and the NAFLD group (). The serum FADS2 concentration in the NAFLD+CAD group was significantly higher than that in the NAFLD group () and the healthy people (). There was no significant difference in genotype distribution (, ) and allele frequency (, ) between the three groups. Logistic regression analysis showed that the T allele was not an independent risk factor for CAD with NAFLD (, 95% CI: 0.422-6.180). Conclusions. Serum FADS2 concentration was positively correlated with the susceptibility of NAFLD with CAD, while the polymorphism of rs3834458 was not associated with NAFLD with CAD. - Open Access
- 8 December 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (2) , 1691-1704
TLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults
TLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults TLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults
- 8 December 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (2) , 1691-1704
Open AccessTLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults
TLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults TLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults
- 1 July 2016
- Published by Elsevier in Virus Research
- Vol. 220, 52-56
Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma
- 1 July 2016
- Published by Elsevier in Virus Research
- Vol. 220, 52-56
Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma